These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25111319)

  • 21. Thiol-based copper handling by the copper chaperone Atox1.
    Hatori Y; Inouye S; Akagi R
    IUBMB Life; 2017 Apr; 69(4):246-254. PubMed ID: 28294521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and dynamics of Cu(I) binding in copper chaperones Atox1 and CopZ: a computer simulation study.
    Rodriguez-Granillo A; Wittung-Stafshede P
    J Phys Chem B; 2008 Apr; 112(15):4583-93. PubMed ID: 18361527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin Binding to Human Copper Chaperone Atox1 and Protein Dimerization.
    Belviso BD; Galliani A; Lasorsa A; Mirabelli V; Caliandro R; Arnesano F; Natile G
    Inorg Chem; 2016 Jul; 55(13):6563-73. PubMed ID: 27305454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cu(I) Controls Conformational States in Human Atox1 Metallochaperone: An EPR and Multiscale Simulation Study.
    Perkal O; Qasem Z; Turgeman M; Schwartz R; Gevorkyan-Airapetov L; Pavlin M; Magistrato A; Major DT; Ruthstein S
    J Phys Chem B; 2020 Jun; 124(22):4399-4411. PubMed ID: 32396355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
    Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
    Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysine-60 in copper chaperone Atox1 plays an essential role in adduct formation with a target Wilson disease domain.
    Hussain F; Rodriguez-Granillo A; Wittung-Stafshede P
    J Am Chem Soc; 2009 Nov; 131(45):16371-3. PubMed ID: 19863064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin handover between copper transporters: the effect of reducing agents.
    Galliani A; Losacco M; Lasorsa A; Natile G; Arnesano F
    J Biol Inorg Chem; 2014 Jun; 19(4-5):705-14. PubMed ID: 24789146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs.
    Barresi V; Spampinato G; Musso N; Trovato Salinaro A; Rizzarelli E; Condorelli DF
    J Inorg Biochem; 2016 Mar; 156():145-52. PubMed ID: 26784148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin adducts on a GGG sequence within a DNA duplex studied by NMR spectroscopy and molecular dynamics simulations.
    Téletchéa S; Skauge T; Sletten E; Kozelka J
    Chemistry; 2009 Nov; 15(45):12320-37. PubMed ID: 19813235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human cytoplasmic copper chaperones Atox1 and CCS exchange copper ions in vitro.
    Petzoldt S; Kahra D; Kovermann M; Dingeldein AP; Niemiec MS; Ådén J; Wittung-Stafshede P
    Biometals; 2015 Jun; 28(3):577-85. PubMed ID: 25673218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation.
    Wang J; Luo C; Shan C; You Q; Lu J; Elf S; Zhou Y; Wen Y; Vinkenborg JL; Fan J; Kang H; Lin R; Han D; Xie Y; Karpus J; Chen S; Ouyang S; Luan C; Zhang N; Ding H; Merkx M; Liu H; Chen J; Jiang H; He C
    Nat Chem; 2015 Dec; 7(12):968-79. PubMed ID: 26587712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atox1 contains positive residues that mediate membrane association and aid subsequent copper loading.
    Flores AG; Unger VM
    J Membr Biol; 2013 Dec; 246(12):903-13. PubMed ID: 24036897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper-chaperones with dicoordinated Cu(I)--unique protection mechanism.
    Ansbacher T; Chourasia M; Shurki A
    Proteins; 2013 Aug; 81(8):1411-9. PubMed ID: 23553875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox sulfur chemistry of the copper chaperone Atox1 is regulated by the enzyme glutaredoxin 1, the reduction potential of the glutathione couple GSSG/2GSH and the availability of Cu(I).
    Brose J; La Fontaine S; Wedd AG; Xiao Z
    Metallomics; 2014 Apr; 6(4):793-808. PubMed ID: 24522867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential roles of Met10, Thr11, and Lys60 in structural dynamics of human copper chaperone Atox1.
    Rodriguez-Granillo A; Wittung-Stafshede P
    Biochemistry; 2009 Feb; 48(5):960-72. PubMed ID: 19146392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro.
    Kahra D; Mondol T; Niemiec MS; Wittung-Stafshede P
    Protein Pept Lett; 2015; 22(6):532-8. PubMed ID: 25962064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unraveling Copper Exchange in the Atox1-Cu(I)-Mnk1 Heterodimer: A Simulation Approach.
    Fortino M; Arnesano F; Pietropaolo A
    J Phys Chem B; 2024 Jun; 128(22):5336-5343. PubMed ID: 38780400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the structural flexibility of the human copper metallochaperone Atox1 dimer and its interaction with the CTR1 c-terminal domain.
    Levy AR; Yarmiayev V; Moskovitz Y; Ruthstein S
    J Phys Chem B; 2014 Jun; 118(22):5832-42. PubMed ID: 24837030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solvent effects and dynamic averaging of 195Pt NMR shielding in cisplatin derivatives.
    Truflandier LA; Sutter K; Autschbach J
    Inorg Chem; 2011 Mar; 50(5):1723-32. PubMed ID: 21204547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper-transfer mechanism from the human chaperone Atox1 to a metal-binding domain of Wilson disease protein.
    Rodriguez-Granillo A; Crespo A; Estrin DA; Wittung-Stafshede P
    J Phys Chem B; 2010 Mar; 114(10):3698-706. PubMed ID: 20166696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.